Can Oracle Reach $800 Per Share by 2030? Here's How It Can Happen

Oracle reported record Q4 FY2026 revenue of $19.18B and cloud infrastructure growth of 93% YoY, with remaining performance obligations surging to $638B. However, the stock is under pressure because FY26 free cash flow fell to -$23.69B on $55.66B of capex, and management guided FY27 net cash capex to $70B. Despite the capex concerns, Wall Street’s consensus target is $252.64, about 37% above the current $184.29 share price.

Analysis

Oracle is transitioning from a software multiple story to an infrastructure financing story, and that re-rating is what the market is struggling to underwrite. The near-term overhang is not demand; it is capital intensity, balance-sheet elasticity, and the possibility that incremental AI revenue still arrives before the associated cash conversion. In the next 1-2 quarters, the stock can stay trapped because investors will haircut every dollar of growth by the probability of refinancing risk and lower incremental free cash flow.

The second-order winner may be IBM, not because it grows faster, but because it offers a cleaner capital-return narrative in a period when public cloud infrastructure is being priced like project finance. If Oracle’s multiple compresses on capex fears, older enterprise IT vendors with steadier cash generation can outperform even without accelerating fundamentals. Morningstar’s lower fair value is relevant less as a target and more as a signal that buy-side models are moving to a higher discount rate on AI infrastructure cash flows.

The key contrarian point is that the market is probably underestimating how fast backlog can translate into earnings power if utilization stays elevated and pricing discipline holds. A $638B backlog with strong GPU utilization means the issue is timing, not necessarily terminal economics; if management de-risks leverage and capex in 6-12 months, the multiple can re-rate before earnings catch up. The bear case is a financing event or digesting phase that forces a reset in FY27/FY28 guidance, which would likely hit the stock harder than any miss on the next print.

Key Decisions for Investors

• Long ORCL on a 3-6 month horizon only on post-selloff weakness, but size modestly: the setup is asymmetric if capex fears stabilize, yet drawdown risk remains high until FY27 funding is clarified.
• Buy ORCL Jan-2027 call spreads rather than outright equity to express the 12-24 month backlog-to-earnings thesis; this limits damage if multiple compression persists while preserving upside if management de-risks capex.
• Pair trade: long IBM / short ORCL for the next 1-2 quarters as a quality-vs-growth-capex relative value expression; the spread should work if the market continues rewarding cash flow visibility over infrastructure scale.
• Avoid chasing ORCL into strength until management demonstrates free-cash-flow inflection or financing clarity; the best entry is likely after any additional capex-induced volatility.
• For tactical hedging, use ORCL put spreads around earnings or capex guidance updates; the stock’s elevated beta makes it vulnerable to 8-12% gap moves on any balance-sheet surprise.